These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 19962890)

  • 41. New 1,3-oxazolo[4,5-c]quinoline derivatives: synthesis and evaluation of antibacterial and antituberculosis properties.
    Eswaran S; Adhikari AV; Ajay Kumar R
    Eur J Med Chem; 2010 Mar; 45(3):957-66. PubMed ID: 20034708
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Selective activity against Mycobacteriumtuberculosis of new quinoxaline 1,4-di-N-oxides.
    Vicente E; Pérez-Silanes S; Lima LM; Ancizu S; Burguete A; Solano B; Villar R; Aldana I; Monge A
    Bioorg Med Chem; 2009 Jan; 17(1):385-9. PubMed ID: 19058970
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Substituted hydrazinecarbothioamide as potent antitubercular agents: synthesis and quantitative structure-activity relationship (QSAR).
    Singh S; Mandal PK; Singh N; Misra AK; Singh S; Chaturvedi V; Sinha S; Saxena AK
    Bioorg Med Chem Lett; 2010 Apr; 20(8):2597-600. PubMed ID: 20304645
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacological evaluation and characterizations of newly synthesized 1,2,4-triazoles.
    Patel NB; Khan IH; Rajani SD
    Eur J Med Chem; 2010 Sep; 45(9):4293-9. PubMed ID: 20630629
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and cytotoxicity of 2-methyl-4, 9-dihydro-1-substituted-1H-imidazo[4,5-g]quinoxaline-4,9-diones and 2,3-disubstituted-5,10-pyrazino[2,3-g]quinoxalinediones.
    Yoo HW; Suh ME; Park SW
    J Med Chem; 1998 Nov; 41(24):4716-22. PubMed ID: 9822542
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis, structural activity relationship and anti-tubercular activity of novel pyrazoline derivatives.
    Ali MA; Shaharyar M; Siddiqui AA
    Eur J Med Chem; 2007 Feb; 42(2):268-75. PubMed ID: 17007966
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis and in vitro evaluation of substituted pyrimido[5,4-d]pyrimidines as a novel class of anti-Mycobacterium tuberculosis agents.
    Bacelar AH; Carvalho MA; Proença MF
    Eur J Med Chem; 2010 Jul; 45(7):3234-9. PubMed ID: 20416983
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 2-aryl-3-(1H-azol-1-yl)-1H-indole derivatives: a new class of antimycobacterial compounds - conventional heating in comparison with MW-assisted synthesis.
    Zampieri D; Mamolo MG; Laurini E; Scialino G; Banfi E; Vio L
    Arch Pharm (Weinheim); 2009 Dec; 342(12):716-22. PubMed ID: 19921681
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Novel substituted quinoxaline 1,4-dioxides with in vitro antimycobacterial and anticandida activity.
    Carta A; Paglietti G; Rahbar Nikookar ME; Sanna P; Sechi L; Zanetti S
    Eur J Med Chem; 2002 May; 37(5):355-66. PubMed ID: 12008050
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular properties prediction and synthesis of novel 1,3,4-oxadiazole analogues as potent antimicrobial and antitubercular agents.
    Ahsan MJ; Samy JG; Khalilullah H; Nomani MS; Saraswat P; Gaur R; Singh A
    Bioorg Med Chem Lett; 2011 Dec; 21(24):7246-50. PubMed ID: 22071303
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis and antimicrobial testing of thiazolinyl-, thiazolidinonyl-quinoxalines and 1,2,4-triazolo[4,3-a]quinoxalines.
    Habib NS; el-Hawash SA
    Pharmazie; 1997 Aug; 52(8):594-8. PubMed ID: 9292917
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis, antibacterial and antimycobacterial activities of some new 4-aryl/heteroaryl-2,6-dimethyl-3,5-bis-N-(aryl)-carbamoyl-1,4-dihydropyridines.
    Sirisha K; Bikshapathi D; Achaiah G; Reddy VM
    Eur J Med Chem; 2011 May; 46(5):1564-71. PubMed ID: 21382653
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Discovery of novel anti-tuberculosis agents with pyrrolo[1,2-a]quinoxaline-based scaffold.
    Wang T; Tang Y; Yang Y; An Q; Sang Z; Yang T; Liu P; Zhang T; Deng Y; Luo Y
    Bioorg Med Chem Lett; 2018 Jun; 28(11):2084-2090. PubMed ID: 29748048
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A note on the antitubercular activities of 1-aryl-5-benzylsulfanyltetrazoles.
    Adamec J; Waisser K; Kunes J; Kaustová J
    Arch Pharm (Weinheim); 2005 Aug; 338(8):385-9. PubMed ID: 16041837
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anti-tubercular agents. Part IV: Synthesis and antimycobacterial evaluation of nitroheterocyclic-based 1,2,4-benzothiadiazines.
    Kamal A; Ahmed SK; Reddy KS; Khan MN; Shetty RV; Siddhardha B; Murthy US; Khan IA; Kumar M; Sharma S; Ram AB
    Bioorg Med Chem Lett; 2007 Oct; 17(19):5419-22. PubMed ID: 17692520
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis of novel substituted pyrazolyl-2-toluidinomethanethione and pyrazolyl-2-methoxyanilinomethanethione as potential antitubercular agents.
    Ali MA; Yar MS
    Acta Pol Pharm; 2007; 64(2):139-46. PubMed ID: 17665863
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis, characterization and in vitro antibacterial activity of new steroidal thiazolo quinoxalines.
    Khan SA; Saleem K; Khan Z
    Eur J Med Chem; 2007 Jan; 42(1):103-8. PubMed ID: 16997429
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis and antimicrobial activity of [2-[2-(N, N-disubstituted thiocarbamoyl-sulfanyl)-acylamino] thiazol-4-yl]acetic acid ethyl esters.
    Ateş O; Gürsoy A; Altintaş H; Otük G; Birteksöz S
    Arch Pharm (Weinheim); 2003 Mar; 336(1):39-46. PubMed ID: 12666252
    [TBL] [Abstract][Full Text] [Related]  

  • 59. L-proline-catalysed facile green protocol for the synthesis and antimycobacterial evaluation of [1,4]-thiazines.
    Indumathi S; Perumal S; Banerjee D; Yogeeswari P; Sriram D
    Eur J Med Chem; 2009 Dec; 44(12):4978-84. PubMed ID: 19781824
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis and biological evaluation of some novel 1,4-dihydropyridines as potential antitubercular agents.
    Trivedi A; Dodiya D; Dholariya B; Kataria V; Bhuva V; Shah V
    Chem Biol Drug Des; 2011 Nov; 78(5):881-6. PubMed ID: 21895982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.